Cytiva BioProcess R&D AB v. JSR Corporation
1:21-cv-00310
Overview
Parties
Defendant
JSR Life Sciences, LLC Operating Company
Represented By
6 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
JSR Micro NV NPE (Individual / Inventor)
Represented By
6 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
JSR Corporation NPE (Individual / Inventor)
Represented By
6 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Plaintiff
Cytiva Sweden AB NPE (Individual / Inventor)
Represented By
7 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Cytiva BioProcess R&D AB Operating Company
Represented By
7 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 10 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🌐 PCT International (WIPO) | PCT World Application | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
JSR Corporation et al. v. Cytiva Bioprocess R&D AB et al.
JSR Corporation et al. v. Cytiva Bioprocess R&D AB et al.
JSR Corporation et al. v. Cytiva Bioprocess R&D AB et al.
JSR Corporation et al. v. Cytiva Bioprocess R&D AB et al.
JSR Corporation et al. v. Cytiva Bioprocess R&D AB et al.
JSR Corporation et al. v. Cytiva Bioprocess R&D AB et al.
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US10213765
Chromatography ligand comprising domain C from Staphylococcus aureus protein A for antibody isolation
|
Filed: 2017-05-23
Issued: 2019-02-26
|
Active (10.5 yrs remaining)
Expires: 2037-05-23
|
|
|
US10343142
Chromatography ligand comprising domain C from Staphylococcus aureus protein A for antibody isolation
|
Filed: 2018-11-13
Issued: 2019-07-09
|
Active (12.0 yrs remaining)
Expires: 2038-11-13
|
|
|
US10875007
Chromatography ligand comprising domain C from Staphylococcus aureus protein A for antibody isolation
|
Filed: 2019-06-17
Issued: 2020-12-29
|
Active (12.6 yrs remaining)
Expires: 2039-06-17
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
22
Dispositive
0
Granted
0
Denied
0
Pending / Review
13
Motions by Category
Key Dispositive Motions & Rulings